Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma

Ming‐Rui Du(Air Force Medical University), Jixian Qian(Air Force Medical University), Zhengcong Cao(Air Force Medical University), Heng Wei(Air Force Medical University), Xiaochang Xue(Massachusetts General Hospital), Fei‐Long Wei(Air Force Medical University), Cheng-Pei Zhou(Air Force Medical University), Yong Zhang(National University of Singapore), Wei Zhang(Liuzhou General Hospital), Nannan Liu(Tianjin University of Science and Technology), Zhe Yu(Air Force Medical University), Kai-Long Zhu(Air Force Medical University), Chenlin Liu(Air Force Medical University), Jintao Gu(Air Force Medical University), Yingwen Wang(Air Force Medical University)
Journal of Experimental & Clinical Cancer Research
April 23, 2022
10.1186/s13046-022-02344-y
Cited by 28

Related Papers

Luminescent nanomaterials for biological labelling
|Nanotechnology|2005|544
Synthesis of polyethylenimine/NaYF<sub>4</sub>nanoparticles with upconversion fluorescence
|Nanotechnology|2006|285
Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma
|ACS Nano|2023|181
Regulation of Osteoimmune Microenvironment and Osteogenesis by 3D‐Printed PLAG/black Phosphorus Scaffolds for Bone Regeneration
|Advanced Science|2023|132
Multifunctional magnesium incorporated scaffolds by 3D-Printing for comprehensive postsurgical management of osteosarcoma
|Biomaterials|2021|121